Literature DB >> 6734955

Weight reduction in boys with muscular dystrophy.

R H Edwards, J M Round, M J Jackson, R D Griffiths, M F Lilburn.   

Abstract

Many children with muscular dystrophy are overweight, and although weight control is pursued in some centres it is unusual to encourage severe dietary restriction for fear that it might lead to accelerated loss of muscle. In this study, two overweight boys with muscular dystrophy were monitored by whole-body nitrogen balance, total body potassium, strength and functional measurements during calorie restriction. Both patients were found to have a transient loss of nitrogen on commencing the low calorie intake: thereafter, weight loss was not found to have any deleterious effect on muscle bulk or function in either patient. It is suggested that controlled weight-reduction in obese children with muscular dystrophy is a safe and practical way of losing excess fat, which can improve mobility and self-esteem, and may possibly effect longevity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734955     DOI: 10.1111/j.1469-8749.1984.tb04457.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  A new chart for weight control in Duchenne muscular dystrophy.

Authors:  R D Griffiths; R H Edwards
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 2.  Respiratory care in muscular dystrophy.

Authors:  J Z Heckmatt
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

3.  Targeting parents for the treatment of pediatric obesity in boys with Duchenne muscular dystrophy: a case series.

Authors:  A Arikian; K Boutelle; C B Peterson; J Dalton; J W Day; S J Crow
Journal:  Eat Weight Disord       Date:  2010-09       Impact factor: 4.652

4.  The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.

Authors:  J H Coakley; J Moorcraft; L J Hipkin; C S Smith; R D Griffiths; R H Edwards
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.